The rapidly advancing field of digital health technologies provides a great opportunity to
radically transform the way clinical trials are conducted and to shift the clinical trial paradigm …

Rheumatic diseases (RDs) are often complicated by chronic symptoms and frequent side-
effects associated with their treatment. Saffron, a spice derived from the Crocus sativus L …

Background and objective: Non-adherence to tacrolimus commonly manifests as low drug
concentrations and/or high intra-patient variability (IPV) of concentrations across multiple …

In response to growing recognition that nonadherence prevents children, adolescents, and
young adults from achieving the therapeutic benefits of anticoagulant medication, the …

Background This review aimed to evaluate the effect of mobile health applications (apps)
use on medication adherence in heart failure (HF) patients, and to verify their quality of use …

Medication non‐adherence, defined as any deviation from the regimen recommended by
their healthcare provider, can increase morbidity, mortality and side effects, while reducing …

The global pharmaceutical industry portfolio is skewed towards cancer and rare diseases
due to more predictable development pathways and financial incentives. In contrast, drug …

Atorvastatin, which has been approved by regulatory agencies for primary-and secondary-
prevention patients with dyslipidemia, has historically been the most commonly prescribed …

Background Poor medication adherence is an extraordinarily common problem worldwide
that contributes to inadequate control of many chronic diseases, including Hypertension …

Medication adherence is a key factor impacting efficacy and safety of medicines, yet how it is
dealt with in European registration trials is unknown. A cross‐sectional analysis of European …